跳至主要内容
临床试验/NCT07176949
NCT07176949招募中不适用

Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai

Shanghai Eye Disease Prevention and Treatment Center1 个研究点 分布在 1 个国家目标入组 508 人开始时间: 2025年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
508
试验地点
1
主要终点
Changes in cycloplegic spherical equivalence

研究概览

简要总结

The prevalence of myopia among children has been increasing year by year, which has become a globle public health issue. Studies have shown that defocusing lenses and atroping eyedrops can control the progression of myopia, but there is little evidence of its efficacy in myopia intervention of young pre-schoolers who will face a greater risk of progression to high myopia later in life. Therefore, this study aims to evaluate the effectiveness and safety of spectacle lenses with highly aspherical lenslets (Essilor's Stellest) , as well as 0.01% and 0.05% low concentration atropine eyedrops in myopia intervention among young children aged 3-6.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 3-6 years, gender unrestricted;
  • Bilateral cycloplegic spherical equivalent (SE) ≤ +0.75 D, astigmatism ≤-2.5 D, anisometropia ≤2.5 D;
  • Best corrected visual acuity: ≥0.5 for ages 3-5, ≥0.7 for age 6;
  • Accept regular follow-up, written informed consent from guardians, verbal informed consent from children;
  • Possess normal thinking and language communication skills, and can actively cooperate to wear spectacles as required.

排除标准

  • Existence of strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, cataract and history of eye surgery;
  • Any ocular or systemic disease that may affect vision and refractive development (e.g., Keratoconus, Marfan syndrome, retinopathy of prematurity, etc.);
  • Current or previous use of other treatments for myopia intervention, such as pharmacological (atropine) and optical (orthokeratology lenses or DIMS spectacle lenses) approaches, interrupt use for at least 4 weeks;
  • Allergy or contraindication to cycloplegic drugs;
  • Epilepsy or other mental disorders unable to expressing consent;
  • Other conditions deemed unsuitable for participation by the researcher.

研究组 & 干预措施

Spectacle Lenses with Highly Aspherical Lenslets

Experimental

Wearing spectacle lenses with highly aspherical lenslets for myopia control

干预措施: Spectacle lenses with highly aspherical lenslets (Device)

0.01% Atropine

Experimental

Nightly use of 0.01% atropine eyedrops for myopia control

干预措施: 0.01% atropine eye drops (Drug)

0.05% Atropine

Experimental

Nightly use of 0.05% atropine eyedrops for myopia control

干预措施: 0.05% atropine eye drops (Drug)

结局指标

主要结局

Changes in cycloplegic spherical equivalence

时间窗: 2 year

Measured by an auto-refractometer

次要结局

  • Proportion of subjects with non-rapid myopia progression(2 years)
  • Changes in axial length(2 years)
  • The duration of non-rapid myopia progression(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验